切换至 "中华医学电子期刊资源库"

中华结直肠疾病电子杂志 ›› 2016, Vol. 05 ›› Issue (05) : 428 -433. doi: 10.3877/cma.j.issn.2095-3224.2016.05.012

所属专题: 文献

综述

结直肠黏液腺癌病理学异质性及与预后的关系
王满香1, 陈琼荣1,()   
  1. 1. 430079 武汉,湖北省肿瘤医院病理科
  • 收稿日期:2016-06-24 出版日期:2016-10-25
  • 通信作者: 陈琼荣
  • 基金资助:
    湖北省自然科学基金资助项目(No.2013CFC022)

The heterogenicity of mucinous colorectal adenocarcinoma and its association with prognosis

Manxiang Wang1, Qiongrong Chen1,()   

  1. 1. Department of Pathology, Hubei Cancer Hospital, Hubei 430079, China
  • Received:2016-06-24 Published:2016-10-25
  • Corresponding author: Qiongrong Chen
  • About author:
    Corresponding author: Chen Qiongrong, Email:
引用本文:

王满香, 陈琼荣. 结直肠黏液腺癌病理学异质性及与预后的关系[J/OL]. 中华结直肠疾病电子杂志, 2016, 05(05): 428-433.

Manxiang Wang, Qiongrong Chen. The heterogenicity of mucinous colorectal adenocarcinoma and its association with prognosis[J/OL]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2016, 05(05): 428-433.

探讨结直肠黏液腺癌临床病理及分子病理异质性。结合临床病理诊断积累的经验,并复习国内外相关文献,总结结直肠黏液腺癌的临床病理特征、微卫星不稳定性及对预后的影响。结直肠黏液腺癌病理形态特征及微卫星不稳定性状态方面的差异,导致不同的临床生物学行为,对治疗的反应及预后均不相同。结直肠黏液腺癌是一类异质性肿瘤,临床病理和分子病理相结合的精准病理诊断,有利于临床治疗方案的选择和预后分层。

To discuss the heterogenicity of mucinous colorectal adenocarcinoma in respect of clinicopathological and molecular pathology. Review of the relevant literatures combining with our experience of pathological diagnosis, we summarize the morphological characteristics, the status of microsatellite and the effect on the prognosis of patients with mucinous colorectal adenocarcinoma. There are obvious difference among the morphological characteristics and the status of microsatellite in the patients with mucinous colorectal adenocarcinoma, which cause different clinic biologic behaviors, different response to treatment and so different prognosis. Mucinous colorectal adenocarcinoma is a kind of heterogeneous cancer. The precise diagnosis combining with the morphology and molecular pathology drawed by the pathologists, which is benefit to select the therapeutic regimen and helpful for prognostic stratification for the patients.

图1 黏液腺癌的不同分化程度(HE染色,×200)。A和B示黏液湖中漂浮的高分化的腺泡状、条索状异型腺体;C显示中分化异型腺体;D示差分化的单个癌细胞或印戒细胞
图2 高倍镜下PDC分级(HE染色,×400):A示<5个PDC,为1级(G1);B示5~9个PDC,为2级(G2);C示≥10个PDC,为3级(G3)
[1]
Jimi Sei-ichiro,Masayuki Hotokezaka,Takuto Ikeda, et al. Clinicopathological features, postoperative survival and prognostic variables for cancer-related survival in patients with mucinous colorectal carcinoma[J]. Surg Today, 2015, 45(3): 329-334.
[2]
Hamilton SR,Bosman FT,Boffetta P, et al. Carcinoma of the colon and rectum. In: Bosman FT,Carneiro F,Hruban RH,Theise ND, eds. WHO Classification of Tumours of the Digestive System[M]. 4th Edition. Lyon: IARC Press, 2010: 134-146.
[3]
Viganò L,Russolillo N,Ferrero A, et al.Resection of liver metastases from colorectal mucinous adenocarcinoma: is this a different disease? Results of a case-control study[J].Ann Surg,2014, 260(5): 878-884.
[4]
Park JS,Huh JW,Park YA, et al. Prognostic comparison between mucinous and nonmucinous adenocarcinoma in colorectal cancer[J]. Medicine (Baltimore), 2015, 94(15): e658.
[5]
Yoon YS,Kim J,Hong SM,et al. Clinical implications of mucinous components correlated with microsatellite instability in patients with colorectal cancer[J].Colorectal Dis, 2015, 17(8): O161-167.
[6]
Lupinacci RM,Mello ES,Coelho FF, et al. Prognostic implication of mucinous histology in resected colorectal cancer liver metastases[J]. Surgery, 2014, 155(6): 1062-1068.
[7]
Debunne H,Ceelen W. Mucinous differentiation in colorectal cancer: molecular, histological and clinical aspects[J]. Acta Chir Belg, 2013, 113(6): 385-390.
[8]
Verhulst J,Ferdinande L,Demetter P, et al. Mucinous subtype as prognostic factor in colorectal cancer: a systematic review and meta-analysis[J]. J ClinPathol, 2012, 65(5): 381-388.
[9]
Yamaguchi T,Taniguchi H,Fujita S, et al. Clinicopathological characteristics and prognostic factors of advanced colorectal mucinous adenocarcinoma[J]. Histopathology, 2012, 61(2): 162-169.
[10]
Ooki A,Akagi K,Yatsuoka T, et al. Inverse effect of mucinous component on survival in stage III colorectal cancer[J]. J Surg Oncol, 2014,110(7): 851-857.
[11]
Yeo SA,Chew MH,Koh PK, et al. Inverse effect of mucinous component on survival in stage III colorectal cancer[J]. Tech Coloproctol, 2013, 17(6): 653-661.
[12]
Langner C,Harbaum L,Pollheimer MJ,et al. Mucinous differentiation in colorectal cancer--indicator of poor prognosis[J]? Histopathology, 2012, 60(7): 1060-1072.
[13]
Nervi M,Gambaccini D,Ambrosini CE, et al. Overall prognosis in younger patients with colorectal carcinoma[J].Minerva Chir, 2006, 61(5): 381-384.
[14]
Razenberg LG,van Gestel YR,Lemmens VE,et al. The Prognostic Relevance of Histological Subtype in Patients With Peritoneal Metastases From Colorectal Cancer: A Nationwide Population-Based Study[J]. Clin Colorectal Cancer, 2015,14(4): e13-e19.
[15]
Hogan J,Burke JP,Samaha G, et al. Overall survival is improved in mucinous adenocarcinoma of the colon[J]. Int J Colorectal Dis, 2014, 29(5): 563-569.
[16]
Hyngstrom JR,Hu CY,Xing Y, et al. Clinicopathology and outcomes for mucinous and signet ring colorectal adenocarcinoma: analysis from the National Cancer Data Base[J]. Ann SurgOncol, 2012, 19(9): 2814-2821.
[17]
Gao P,Song YX,Xu YY, et al. Does the prognosis of colorectal mucinous carcinoma depend upon the primary tumour site? Results from two independent databases[J]. Histopathology, 2013, 63(5): 603-615.
[18]
Safaee A,Moghimi-Dehkordi B,Fatemi SR et al. Characteristics of colorectal mucinous adenocarcinoma in Iran[J]. Asian Pac J Cancer Prev, 2010, 11(5): 1373-1375.
[19]
Chen JX,Tang XD,Xiang DB, et al. TNM stages and prognostic features of colorectal mucinous adenocarcinomas: a meta analysis[J]. Asian Pac J Cancer Prev, 2012, 13(7): 3427-3430.
[20]
Kang H,O'Connell JB,Maggard MA, et al. A 10-year outcomes evaluation of mucinous and signet-ring cell carcinoma of the colon and rectum[J]. Dis Colon Rectum, 2005, 48(6): 1161-1168.
[21]
Jivapaisarnpong P,Boonthongtho K. Clinicopathological characteristics of mucinous and non- mucinous adenocarcinoma in the colon andrectum in Rajavithi Hospital, Thailand[J]. J Med Assoc Thai, 2011, 94(Suppl 2): S41-S45.
[22]
Zlobec I,Bihl MP,Foerster A, et al. The impact of CpG island methylator phenotype and microsatellite instability on tumour budding in colorectal cancer[J]. Histopathology, 2012, 61(5): 777-787.
[23]
Betge J,Kornprat P,Pollheimer MJ, et al. Tumor budding is an independent predictor of outcome in AJCC/UICC stage II colorectal cancer[J]. Ann SurgOncol, 2012, 19(12): 3706-3712.
[24]
Barresi V,ReggianiBonetti L,Ieni A, et al. Histological grading in colorectal cancer: new insights and perspectives[J]. HistolHistopathol, 2015, 30(9): 1059-1067.
[25]
Ueno H,Kajiwara Y,Shimazaki H, et al. New criteria for histologic grading of colorectal cancer[J]. Am J SurgPathol, 2012, 36(2): 193-201.
[26]
Ueno H,Hase K,Hashiguchi Y,et al. Site-specific tumor grading system in colorectal cancer: multicenter pathologic review of the value of quantifying poorly differentiated clusters[J]. Am J Surg Pathol, 2014, 38(2): 197-204.
[27]
Barresi V,Bonetti LR,Ieni A, et al. Histologic grading based on counting poorly differentiated clusters in preoperative biopsy predicts nodal involvement and pTNM stage in colorectal cancer patients[J]. Hum Pathol, 2014, 45(2): 268-275.
[28]
Barresi V,ReggianiBonetti L,Branca G, et al. Colorectal carcinoma grading by quantifying poorly differentiated cell clusters is more reproducible and provides more robust prognostic information than conventional grading[J].Virchows Arch, 2012, 461(6): 621-628.
[29]
Ueno H,Shinto E,Kajiwara Y, et al. Prognostic impact of histological categorisation of epithelial-mesenchymal transition in colorectal cancer[J]. Br J Cancer, 2014, 111(11): 2082-2090.
[30]
Barresi V,ReggianiBonetti L,Ieni A, et al. Prognostic significance of grading based on the counting of poorly differentiated clusters in colorectal mucinousadenocarcinoma[J]. Hum Pathol, 2015, 46(11): 1722-1729.
[31]
Moreira L,Balaguer F,Lindor N, et al. Identification of Lynch syndrome among patients with colorectal cancer[J]. JAMA, 2012, 308(15): 1555-1565.
[32]
Kane MF,Loda M,Gaida GM,et al. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines[J]. Cancer Res, 1997, 57(5): 808-811.
[33]
Guastadisegni C,Colafranceschi M,Ottini L, et al. Microsatellite instability as a marker of prognosis and response to therapy: a meta-analysis of colorectal cancer survival data[J]. Eur J Cancer, 2010, 46(15): 2788-2298.
[34]
Benatti P,Gafà R,Barana D, et al. Microsatellite instability and colorectal cancer prognosis[J]. Clin Cancer Res, 2005, 11(23): 8332-8340.
[35]
Sinicrope FA,Rego RL,Halling KC, et al. Prognostic impact of microsatellite instability and DNA ploidy in human colon carcinoma patients[J]. Gastroenterology, 2006, 131(3): 729-737.
[36]
Rosty C,Williamson EJ,Clendenning M, et al. Should the grading of colorectal adenocarcinoma include microsatellite instability status[J]? Hum Pathol,2014, 45(10): 2077-2084.
[37]
Barresi V,Bonetti LR. Correlation between microsatellite instability status and grading assessed by the counting of poorly differentiated clusters in colorectal cancer[J]. Hum Pathol, 2015, 46(7): 1063.
[38]
秦云,梁莉萍,郑兴征,等.免疫组织化学法检测结直肠癌四种DNA错配修复蛋白表达缺失对判断肿瘤微卫星状态的价值[J]. 中华病理学杂志, 2015, 44(10): 704-708.
[1] 汪洪斌, 张红霞, 何文, 杜丽娟, 程令刚, 张雨康, 张萌. 低级别阑尾黏液性肿瘤与阑尾黏液腺癌超声及超声造影特征分析[J/OL]. 中华医学超声杂志(电子版), 2024, 21(09): 865-871.
[2] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[3] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[4] 徐逸男. 不同术式治疗梗阻性左半结直肠癌的疗效观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 72-75.
[5] 李代勤, 刘佩杰. 动态增强磁共振评估中晚期低位直肠癌同步放化疗后疗效及预后的价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 100-103.
[6] 梁孟杰, 朱欢欢, 王行舟, 江航, 艾世超, 孙锋, 宋鹏, 王萌, 刘颂, 夏雪峰, 杜峻峰, 傅双, 陆晓峰, 沈晓菲, 管文贤. 联合免疫治疗的胃癌转化治疗患者预后及术后并发症分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 619-623.
[7] 张志兆, 王睿, 郜苹苹, 王成方, 王成, 齐晓伟. DNMT3B与乳腺癌预后的关系及其生物学机制[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 624-629.
[8] 屈翔宇, 张懿刚, 李浩令, 邱天, 谈燚. USP24及其共表达肿瘤代谢基因在肝细胞癌中的诊断和预后预测作用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 659-662.
[9] 顾雯, 凌守鑫, 唐海利, 甘雪梅. 两种不同手术入路在甲状腺乳头状癌患者开放性根治性术中的应用比较[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 687-690.
[10] 付成旺, 杨大刚, 王榕, 李福堂. 营养与炎症指标在可切除胰腺癌中的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 704-708.
[11] 关小玲, 周文营, 陈洪平. PTAAR在乙肝相关慢加急性肝衰竭患者短期预后中的预测价值[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 841-845.
[12] 张润锦, 阳盼, 林燕斯, 刘尊龙, 刘建平, 金小岩. EB病毒相关胆管癌伴多发转移一例及国内文献复习[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 865-869.
[13] 王景明, 王磊, 许小多, 邢文强, 张兆岩, 黄伟敏. 腰椎椎旁肌的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 846-852.
[14] 郭曌蓉, 王歆光, 刘毅强, 何英剑, 王立泽, 杨飏, 汪星, 曹威, 谷重山, 范铁, 李金锋, 范照青. 不同亚型乳腺叶状肿瘤的临床病理特征及预后危险因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 524-532.
[15] 闫维, 张二明, 张克, 安欣华, 向平超. 北京市石景山区40岁及以上居民早期慢性阻塞性肺疾病异质性及影响因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 533-540.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?